Yuhan Corp (000100) Stock Price & News

000100:KRX

Yuhan Corp

₩79,400.00

+0.63%

(+500.00) 1D

Sep 11, 3:30:25 PM GMT+9 · KRW

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 000100...

Open

₩78,200

High

₩79,800

Low

₩77,700

Mkt. cap

5.92T

Avg. vol.

273.40K

Volume

137.72K

Dividend

0.76%

Quarterly dividend

₩150

Ex-dividend date

Feb 26, 2026

P/E ratio

24.96

52-wk high

₩129,200

52-wk low

₩65,000

EPS

₩3,181

Shares outstanding

73.62M

No. of employees

Open

₩78,200

High

₩79,800

Low

₩77,700

Mkt. cap

5.92T

Avg. vol.

273.40K

Volume

137.72K

Dividend

0.76%

Quarterly dividend

₩150

Ex-dividend date

Feb 26, 2026

P/E ratio

24.96

52-wk high

₩129,200

52-wk low

₩65,000

EPS

₩3,181

Shares outstanding

73.62M

No. of employees

Related stocks

009830

Hanwha Solutions Corp

₩29,800.00

-1.49%

005930

Samsung Electronics Co Ltd

Profile

Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia

About Yuhan Corp

CEOWook Je Cho

Employees2.09K

Founded1926

Headquarters-

SectorPharmaceutical industry

Websiteyuhan.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	570.01B	546.07B	526.78B	639.45B
Cost of goods sold	401.57B	333.27B	377.63B	411.75B
Cost of revenue	401.57B	333.27B	377.63B	411.75B
Research and development expenses	45.94B	78.04B	47.24B	60.12B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	94.69B	103.16B	88.43B	99.40B
Operating expense	146.43B	185.79B	140.37B	160.70B
Total operating expenses	548.00B	519.05B	518.00B	572.45B
Operating income	22.01B	27.02B	8.78B	67.00B
Other non operating income	-2.09B	-4.58B	231.25M	-6.59B
EBT including unusual items	35.18B	120.91B	28.76B	88.37B
EBT excluding unusual items	34.24B	112.36B	26.45B	84.89B
Income tax expense	14.01B	10.77B	5.39B	20.33B
Effective tax rate	39.83%	8.91%	18.75%	23.00%
Other operating expenses	1.68B	3.00B	1.94B	2.87B
Net income	25.28B	114.43B	27.04B	70.32B
Net profit margin	4.44%	20.96%	5.13%	11.00%
Earnings per share	348.00	1.53K	372.00	950.00
Interest and investment income	2.11B	2.13B	2.35B	2.47B
Interest expense	-3.99B	-3.91B	-3.86B	-3.89B
Net interest expenses	-1.88B	-1.77B	-1.51B	-1.42B
Depreciation and amortization charges	2.12B	962.24M	1.52B	1.48B
EBITDA	40.00B	44.17B	27.88B	90.47B
Gain or loss from assets sale	9.44M	-9.65B	15.64M	291.06M

Finance

Ask anything